Paper Details
- Home
- Paper Details
Antipsychotic Safety in Liver Disease: A Narrative Review and Practical Guide for the Clinician.
Author: DopheideJulie A, GuntherMatthew
Original Abstract of the Article :
BACKGROUND: Clinicians treating psychiatric disorders in medically ill patients need a comprehensive resource for comparing the risk and types of liver injury associated with antipsychotic therapy. OBJECTIVE: We conducted a narrative review aimed at developing a comprehensive resource comparing ant...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.jaclp.2022.09.006
データ提供:米国国立医学図書館(NLM)
Antipsychotics and Liver Health: A Guide for Clinicians
This study provides a comprehensive review of the potential risks associated with antipsychotic medications in patients with liver disease. The authors compiled information from various sources to compare different antipsychotics based on their risk of inducing or worsening liver injuries. This review offers valuable guidance for clinicians managing psychiatric disorders in patients with liver disease.
Navigating the Risks of Antipsychotics in Liver Disease
The study highlights the importance of carefully considering the risk-benefit profile of antipsychotic medications in patients with liver disease. Some antipsychotics, such as chlorpromazine, clozapine, and olanzapine, pose a higher risk of hepatotoxicity compared to others. Clinicians must weigh the potential benefits of treating psychosis against the potential risks to liver health. It's like navigating a desert with various paths, each with its own risks and rewards.
Individualized Management of Antipsychotic Therapy
The study emphasizes the importance of individualizing antipsychotic therapy for patients with liver disease. This involves careful patient selection, dose adjustment, regular monitoring, and patient counseling. Clinicians should consider the patient's existing liver condition, the specific antipsychotic being prescribed, and the potential for side effects. Just like a desert traveler chooses the appropriate gear for their journey, clinicians must select and manage antipsychotic therapy with careful consideration.
Dr.Camel's Conclusion
This review provides valuable guidance for clinicians treating psychiatric disorders in patients with liver disease. It emphasizes the importance of careful risk-benefit analysis, individualized therapy, and ongoing monitoring. It's like a guidebook for traversing a complex and challenging desert, providing essential knowledge for navigating the risks and rewards of antipsychotic therapy in patients with liver disease.
Date :
- Date Completed 2023-02-14
- Date Revised 2023-05-24
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.